Scrip Dividend Scheme

RNS Number : 0975T
Allocate Software PLC
14 November 2013
 



14 November 2013

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

 

Scrip Dividend Scheme

 

The Board of Allocate Software plc (the "Company") confirmed in an announcement on 31 July 2013 that a scrip alternative to the forthcoming final dividend will be available to shareholders under the terms of the Company's Scrip Dividend Scheme (the "Scheme").

 

The scrip calculation price in relation to the final dividend due to be paid on 5 December 2013 is 106.9p per share. This is the average of the closing middle-market quotations for the Company's ordinary shares as derived from the London Stock Exchange Daily Official List for the five dealing days commencing on the ex-dividend date 6 November 2013.

 

Shareholders wishing to participate in the Scheme (unless they have already elected to do so) should submit a completed Scrip Mandate Form to the Share Registrar, Capita Asset Services, by 5.00pm on 15 November 2013. Scrip Mandate Forms are available from the Share Registrar by calling 0871 664 0300 from within the UK and +44 20 8639 3399 if calling from outside the UK, subject to standard UK or international charges as applicable.

 

Alternatively, shareholders can elect to participate online via the Capita Share Portal at www.capitashareportal.com. Shareholders who hold shares in uncertificated form in CREST should submit elections via CREST by 5.00pm on 15 November 2013. Shareholders wishing to revoke previously submitted Scrip Mandate Forms should also contact the Share Registrar by 5.00pm on 15 November 2013.

 

Full details of the Scheme are available on the Company's website, www.allocatesoftware.com.

 

 

Enquiries:

Allocate Software plc

Chris Gale - Chief Financial Officer

                                                     

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

 

Tel: +44 (0) 20 7193 7463

       +44 (0) 7525 324 431

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGGBPGUPWGMC
UK 100

Latest directors dealings